ASO Author Reflections: Impact of Salvage Surgery in Unresectable Hepatocellular Carcinoma After Conversion Therapy: Should it be Recommended?

被引：0
作者：
Wu, Jun-Yi [1 ,2 ]
Wu, Jia-Yi [1 ,2 ]
Fu, Yang-Kai [1 ,2 ]
Yan, Mao-Lin [1 ,2 ]
机构：
[1] Fujian Med Univ, Fujian Prov Hosp, Shengli Clin Med Coll, Dept Hepatobiliary Pancreat Surg, Fuzhou, Peoples R China
[2] Fujian Prov Hosp, Dept Hepatobiliary Pancreat Surg, Fuzhou, Peoples R China
来源：
ANNALS OF SURGICAL ONCOLOGY | 2024年 / 31卷 / 05期
关键词：
D O I：
10.1245/s10434-024-14991-w
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：3100 / 3101
页数：2
相关论文
共 5 条
[1]   Outcomes and prognostic factors in initially unresectable hepatocellular carcinoma treated using conversion therapy with lenvatinib and TACE plus PD-1 inhibitors [J].
Li, Xingzhi ;
Chen, Jie ;
Wang, Xiaobo ;
Bai, Tao ;
Lu, Shaolong ;
Wei, Tao ;
Tang, Zhihong ;
Huang, Chengwen ;
Zhang, Bin ;
Liu, Bowen ;
Li, Lequn ;
Wu, Feixiang .
FRONTIERS IN ONCOLOGY, 2023, 13
[2]   Outcomes of Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma Converted by Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Antibodies: A Multicenter Retrospective Study [J].
Wu, Jia-Yi ;
Zhang, Zhi-Bo ;
Zhou, Jian-Yin ;
Ke, Jing-Peng ;
Bai, Yan-Nan ;
Chen, Yu-Feng ;
Wu, Jun-Yi ;
Zhou, Song-Qiang ;
Wang, Shuang-Jia ;
Zeng, Zhen-Xin ;
Li, Yi-Nan ;
Qiu, Fu-Nan ;
Li, Bin ;
Yan, Mao-Lin .
LIVER CANCER, 2023, 12 (03) :229-237
[3]   Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study [J].
Wu, Jia-Yi ;
Yin, Zhen-Yu ;
Bai, Yan-Nan ;
Chen, Yu-Feng ;
Zhou, Song-Qiang ;
Wang, Shuang-Jia ;
Zhou, Jian-Yin ;
Li, Yi-Nan ;
Qiu, Fu-Nan ;
Li, Bin ;
Yan, Mao-Lin .
JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 :1233-1240
[4]   Outcomes of Salvage Surgery Versus Non-Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma After Conversion Therapy with Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Antibody: A Multicenter Retrospective Study [J].
Wu, Jun-Yi ;
Wu, Jia-Yi ;
Fu, Yang-Kai ;
Ou, Xiang-Ye ;
Li, Shu-Qun ;
Zhang, Zhi-Bo ;
Zhou, Jian-Yin ;
Li, Bin ;
Wang, Shuang-Jia ;
Chen, Yu-Feng ;
Yan, Mao-Lin .
ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (05) :3073-3083
[5]   Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma [J].
Zhu, Xiao-Dong ;
Huang, Cheng ;
Shen, Ying-Hao ;
Xu, Bin ;
Ge, Ning-Ling ;
Ji, Yuan ;
Qu, Xu-Dong ;
Chen, Lingli ;
Chen, Yi ;
Li, Mei-Ling ;
Zhu, Jin-Jin ;
Tang, Zhao-You ;
Zhou, Jian ;
Fan, Jia ;
Sun, Hui-Chuan .
ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (05) :2782-2790
1